Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF

NCT00952237 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkin's Lymphoma
Hodgkin's Disease
Multiple Myeloma
Other Plasma Cell Dyscrasia (Waldenstrom, Amyloidosis)
Leukemia

Interventions

DRUG: GM-CSF
DRUG: IL-2

Sponsor

Dartmouth-Hitchcock Medical Center